Ovarian metastases represent about 3-5% of all ovarian malignancies. Most of these tumors originate in the digestive tract and cholangiocarcinoma rarely involves the ovary. A 60-year-old woman was admitted for the investigation of abdominal distension that had lasted 1 week. One and a half years prior, the patient had undergone choledochal cyst excision, Roux-en Y hepaticojejunostomy and cholecystectomy. Computed tomography scans of the abdomen revealed a papillary mass in the remnant distal common bile duct and enlargement of both ovaries with a huge amount of ascites. An explorative laparotomy disclosed no peritoneal seeding with resectable cholangiocarcinoma and bilateral ovarian mass. Pylorus-preserving pancreatoduodenectomy and bilateral salphingo-oophorectomy with hysterectomy were performed. Histologically, it was a well-differentiated adenocarcinoma and all surgical margins were free of tumor. Both ovarian masses were consistent with metastatic adenocarcinoma from the common bile duct. The patient received six cycles of postoperative adjuvant systemic chemotherapy, dying after 10 months due to pulmonary embolism. 
INTRODUCTION
Ovarian metastases represent about 3-5% of all ovarian malignancies. 1 Because they occasionally mimic the clinical and morphological appearance of primary tumors, diagnosis is difficult. The majority of these neoplasias originate from the digestive tract, particularly from stomach and biliary tract, cholangiocarcinomas are very rare tumors that rarely involve the ovary. We present a very unusual case of metastatic carcinoma of the common bile duct originating from a choledochal cyst presenting as an ovarian metastasis in a 60-year-old woman.
CASE
A 60-year-old woman was admitted for the investigation of abdominal distension that had lasted for 1 week. One 
DISCUSSION
The present case featured two unusual findings: cancer deveolpment from remnant distal CBD after choeldochal cyst excision and bilateral ovarian metastases from cholangiocacinoma.
Theoretically, biliary malignancy should not develop after excision of the choledochal cyst because the presumed cause was abrogated by separation-operation. However, although the incidence of biliary malignancy after excision of a choledochal cyst was 0.6% in Korean multicenter study 2 and 0.7% in a Japanese nationwide study, 3 imum tumor volume reduction, which is advantageous for survival. 6 However, very few cases documenting ovarian metastases from cholangiocarcinoma have been reported in the literature, 7, 8 so the benefit of ovarian metastatectomy remains to be elucidated. Bilateral oophorectomy for ovarian metastasis from colorectal cancer has a positive impact on disease-free and overall survival in isolated ovarian metastases patients in an Italian study. 9 Also, for patients with gastric cancer, a Korean study suggested that debulking or gastrectomy plus metastasectomy may confer survival benefits on patients with distant metastases who are receiving systemic chemotherapy. 10 However, since the prognosis of ovarian metastasis is dismal, and the benefit of ovarian metastatectomy is limited, further investigation is needed.
The present case is the first reported case of ovarian metastasis from cholangiocarcinoma associated with a choledochal cyst. Since biliary malignancy could develop within a relatively short period after choledochal cyst excision, regular follow-up should be done for early detection of subsequent biliary malignancy after cyst excision. Although most reported cases with ovarian metastasis from cholangiocarcinoma were treated with bilateral salphigo-oophorectomy, the benefit of ovarian metastatectomy is uncertain and should be investigated.
